Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

P53 mediates ceramide-induced apoptosis in SKN-SH cells

Abstract

Ceramide induces apoptotic cell death in a dose- and time-dependent manner in neuroblastoma SKN-SH cells. Pretreatment with caspase inhibitors blocks cell death, suggesting that a set of caspase activities including caspase 1, as well as caspase 3, are involved in ceramide-induced apoptosis in SKN-SH cells. Treatment with a caspase inhibitor 3 h after ceramide addition did not inhibit cell death, although caspase activity was substantially reduced. Ceramide-induced apoptosis is accompanied by accumulation of p53 followed by an increase of Bax and decrease of Bcl-2 levels. Inhibition of p53 expression with p53 antisense oligonucleotides inhibits apoptosis and prevents the increase in Bax and decrease in Bcl-2. Furthermore, pretreatment with p53 antisense oligonucleotides markedly inhibits the induction of caspase activity. These results suggest that p53 regulates the ratio Bcl-2/Bax and the expression/activation of caspases during ceramide-induced apoptosis in SKN-SH cells. Caspase inhibition did not alter the expression of p53, Bcl-2 and Bax. Thus ceramide-induced reduction in the Bcl-2/Bax ratio, increase in caspase activity, and apoptosis is dependent upon increases in cellular p53 levels which play a critical role in the regulation of apoptotic cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Ali ST, Coggins JR, Jacobs HT . 1997 Biochem. J. 325: 321–324

  • Allouche M, Bettaieb A, Vindis C, Rousse A, Grignon C, Laurent G . 1997 Oncogene 14: 1837–1845

  • Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J . 1996 Cell 87: 171–

  • Anjum R, Ali AM, Begum Z, Vanaja J, Khar A . 1998 FEBS Lett. 439: 81–84

  • Bradford MM . 1976 Anal. Biochem. 72: 248–254

  • Brugg B, Michel PP, Agid Y, Ruberg M . 1996 J. Neurochem. 66: 733–739

  • Choisy-Rossi C, Reisdorf P, Yonish-Rouach E . 1998 Toxicol. Lett. 102–103: 491–496

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH . 1993 Nature 362: 849–852

  • Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA . 1998 J. Clin. Invest. 102: 329–339

  • Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M . 1995 EMBO J. 14: 1136–1144

  • El-Assaad W, El-Sabban M, Awaraji C, Abboushi N, Dbaibo GS . 1998 Biochem. J. 336: 735–741

  • France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M . 1997 J. Neurochem. 69: 1612–1621

  • Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J . 1997 J. Exp. Med. 185: 933–940

  • Graeber TG, Peterson JF, Tsai M, Monica K, Fornace Jr AJ, Giaccia AJ . 1994 Mol. Cell Biol. 14: 6264–6277

  • Han J, Sabbatini P, Perez D, Rao L, Modha D, White E . 1996 Genes 10: 461–477

  • Hartfield PJ, Bilney AJ, Murray AW . 1998 J. Neurochem. 71: 161–169

  • Hartfield PJ, Mayne GC, Murray AW . 1997 FEBS Lett. 401: 148–152

  • Haupt Y, Barak Y, Oren M . 1996 EMBO J. 15: 1596–1606

  • Johnson Jr EM, Deckwerth TL . 1993 Annu. Rev. Neurosci. 16: 31–46

  • Kim SS, Kang MS, Choi YM, Suh YH, Kim DK . 1997 Biochem. Biophys. Res. Commun. 237: 583–587

  • Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ . 1995 Science 270: 96–99

  • Laemmli UK . 1970 Nature 227: 680–685

  • Levine AJ . 1997 Cell 88: 323–331

  • Lightle SA, Oakley JI, Nikolova-Karakashian MN . 2000 Mech. Ageing Dev. 120: 111–125

  • Martin SJ, Green DR . 1995 Cell. 82: 349–352

  • Mathias S, Pena LA, Kolesnick RN . 1998 Biochem. J. 335: 465–480

  • Mesner PW, Winters TR, Green SH . 1992 J. Cell Biol. 119: 1669–1680

  • Mizushima N, Koike R, Kohsaka H, Kushi Y, Handa S, Yagita H, Miyasaka N . 1996 FEBS Lett. 395: 267–271

  • Oltvai ZN, Milliman CL, Korsmeyer SJ . 1993 Cell 74: 609–619

  • Reed JC . 1990 Nature 387: 773–776

  • Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ . 1995 Proc. Natl. Acad. Sci. USA 92: 7834–7838

  • Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D . 1994 Oncogene 9: 1791–1798

  • Thornberry NA . 1997 Br. Med. Bull. 53: 478–490

  • Vaneble M, Lee J, Smyth M, Bielawska A, Obeid LM . 1995 J. Biol. Chem. 270: 30701–30708

  • Wieder T, Geilen CC, Kolter T, Sadeghlar F, Sandhoff K, Brossmer R, Ihrig P, Perry D, Orfanos CE, Hannun YA . 1997 FEBS Lett. 411: 260–264

  • Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ . 1995 Cell 80: 285–291

  • Zha H, Aime-Sempe C, Sato T, Reed JC . 1996 J. Biol. Chem. 271: 7440–7444

  • Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA . 1996 Proc. Natl. Acad. Sci. USA 93: 5325–5328

Download references

Acknowledgements

This research was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (01-PJ8-PG1-01CN2-0003), Korea Science and Engineering Foundation Grant (2000-2-21300-004-3), Korea Research Foundation Grant (KRF-2000-015-FP0045), and National Creative Research Initiative Program from MOST (2000-2003). JV Bonventre was supported by grants from the National Institutes of Health DK 39773, DK 38452 and NS 10828.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph V Bonventre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S., Chae, HS., Bach, JH. et al. P53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene 21, 2020–2028 (2002). https://doi.org/10.1038/sj.onc.1205037

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205037

Keywords

This article is cited by

Search

Quick links